Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panluminate has developed a proprietary expansion microscopy platform that allows 3D expansion of cell and tissue samples up to 25x while preserving ultrastructural integrity. Their commercial service enables researchers to achieve electron microscopy-like resolution (~10nm) using standard confocal microscopes. The platform supports multiplexed fluorescent labeling (>50 proteins per sample) without tissue degradation and is being adopted by pharmaceutical companies and academic labs for applications in drug discovery, pre-clinical development, digital pathology, and biomarker validation. As of mid 2024 the company had over 20 paying customers across pharma/biotech/startups/universities
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panluminate.